Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
PecFent 400micrograms/dose nasal spray
0407020A0BPABBP
|
PecFent | Fentanyl | Central Nervous System | 23 |
|
Fentanyl 800microgram buccal tablets sugar free
0407020A0AABGBG
|
Fentanyl | Fentanyl | Central Nervous System | 20 |
|
Fenylat 25micrograms/hour transdermal patches
0407020A0BZABAE
|
Fenylat | Fentanyl | Central Nervous System | 17 |
|
Fenylat 12micrograms/hour transdermal patches
0407020A0BZAAAU
|
Fenylat | Fentanyl | Central Nervous System | 16 |
|
Actiq 1.6mg lozenges with integral oromucosal applicator
0407020A0BCAFAP
|
Actiq | Fentanyl | Central Nervous System | 13 |
|
Effentora 600microgram buccal tablets
0407020A0BKADBF
|
Effentora | Fentanyl | Central Nervous System | 11 |
|
Fentanyl 400micrograms/dose nasal spray
0407020A0AABPBP
|
Fentanyl | Fentanyl | Central Nervous System | 10 |
|
Effentora 800microgram buccal tablets
0407020A0BKAEBG
|
Effentora | Fentanyl | Central Nervous System | 9 |
|
Fentanyl 1.2mg lozenges
0407020A0AAANAN
|
Fentanyl | Fentanyl | Central Nervous System | 9 |
|
Fenylat 50micrograms/hour transdermal patches
0407020A0BZACAF
|
Fenylat | Fentanyl | Central Nervous System | 7 |
|
Cynril 600microgram loz with integral oromucosal applicator
0407020A0BWACAK
|
Cynril | Fentanyl | Central Nervous System | 6 |
|
Opiodur 12micrograms/hour transdermal patches (RX Farma)
0407020A0BRAFAU
|
Opiodur | Fentanyl | Central Nervous System | 6 |
|
Actiq 1.2mg lozenges with integral oromucosal applicator
0407020A0BCAEAN
|
Actiq | Fentanyl | Central Nervous System | 5 |
|
Opiodur 50micrograms/hour transdermal patches (RX Farma)
0407020A0BRAHAF
|
Opiodur | Fentanyl | Central Nervous System | 5 |
|
Fenhuma 100microgram sublingual tablets
0407020A0BXAAAW
|
Fenhuma | Fentanyl | Central Nervous System | 4 |
|
Fentanyl 67microgram sublingual tablets sugar free
0407020A0AACHCH
|
Fentanyl | Fentanyl | Central Nervous System | 4 |
|
Fenylat 100micrograms/hour transdermal patches
0407020A0BZAEAH
|
Fenylat | Fentanyl | Central Nervous System | 4 |
|
Iremia 400microgram sublingual tablets
0407020A0BYAPAZ
|
Iremia | Fentanyl | Central Nervous System | 4 |
|
Cynril 1.6mg lozenges with integral oromucosal applicator
0407020A0BWAFAP
|
Cynril | Fentanyl | Central Nervous System | 3 |
|
Fentalis Reservoir 50micrograms/hour transdermal patches
0407020A0BGABAF
|
Fentalis | Fentanyl | Central Nervous System | 2 |
|
Fenylat 75micrograms/hour transdermal patches
0407020A0BZADAG
|
Fenylat | Fentanyl | Central Nervous System | 2 |
|
Fenhuma 200microgram sublingual tablets
0407020A0BXAFAX
|
Fenhuma | Fentanyl | Central Nervous System | 1 |
|
Fentalis Reservoir 100micrograms/hour transdermal patches
0407020A0BGADAH
|
Fentalis | Fentanyl | Central Nervous System | 1 |
|
Fentalis Reservoir 25micrograms/hour transdermal patches
0407020A0BGAAAE
|
Fentalis | Fentanyl | Central Nervous System | 1 |
|
Fentalis Reservoir 75micrograms/hour transdermal patches
0407020A0BGACAG
|
Fentalis | Fentanyl | Central Nervous System | 1 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.